COSMOPHOS-NANO
Novel nanotechnology-enabled system for endovascular in vivo near-infrared fluorescence molecular imaging and endovascular near-infrared targeted photodynamic therapy of atherosclerotic heart disease
| Coordinatore | Itä-Suomen yliopisto
Organization address
address: YLIOPISTONRANTA 1 E contact info |
| Nazionalità Coordinatore | Finland [FI] |
| Sito del progetto | http://www.cosmophos-nano.eu/ |
| Totale costo | 12˙899˙591 € |
| EC contributo | 8˙503˙352 € |
| Programma | FP7-NMP
Specific Programme "Cooperation": Nanosciences, Nanotechnologies, Materials and new Production Technologies |
| Code Call | FP7-NMP-2012-LARGE-6 |
| Funding Scheme | CP-IP |
| Anno di inizio | 2013 |
| Periodo (anno-mese-giorno) | 2013-03-01 - 2018-02-28 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
Nome Ente NON disponibile
Organization address
address: YLIOPISTONRANTA 1 E contact info |
FI (Kuopio) | coordinator | 2˙029˙689.60 |
| 2 | KOBENHAVNS UNIVERSITET | DK | participant | 844˙768.00 |
| 3 |
UNIVERSIDAD AUTONOMA DE MADRID
Organization address
address: CALLE EINSTEIN, CIUDAD UNIV CANTOBLANCO RECTORADO 3 contact info |
ES (MADRID) | participant | 679˙426.00 |
| 4 |
TECHNISCHE UNIVERSITAET MUENCHEN
Organization address
address: Arcisstrasse 21 contact info |
DE (MUENCHEN) | participant | 657˙547.00 |
| 5 |
FREIE UNIVERSITAET BERLIN
Organization address
address: Kaiserswertherstrasse 16-18 contact info |
DE (BERLIN) | participant | 523˙735.00 |
| 6 |
TOXI-COOP TOXIKOLOGIAI KUTATO KOZPONT ZARTKORUEN MUKODO RT
Organization address
address: DERES UTCA 10 A contact info |
HU (BUDAPEST) | participant | 500˙275.00 |
| 7 |
COSMOPHOS LTD
Organization address
address: ADRIANOUPOLEOS 1A contact info |
EL (THESSALONIKI) | participant | 499˙540.00 |
| 8 |
EURAM LIMITED
Organization address
address: "Tower House, Lucy Tower Street" contact info |
UK (LINCOLN) | participant | 374˙400.00 |
| 9 |
POHJOIS-SAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA
Organization address
address: Puijonlaaksontie 2 contact info |
FI (Kuopio) | participant | 346˙895.20 |
| 10 |
STICHTING KATHOLIEKE UNIVERSITEIT
Organization address
address: GEERT GROOTEPLEIN NOORD 9 contact info |
NL (NIJMEGEN) | participant | 328˙120.00 |
| 11 |
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE
Organization address
address: "Via Adamello, 16" contact info |
IT (MILAN) | participant | 312˙592.40 |
| 12 |
KATHOLIEKE UNIVERSITEIT LEUVEN
Organization address
address: Oude Markt 13 contact info |
BE (LEUVEN) | participant | 310˙088.00 |
| 13 |
BIOCONTRACT SP ZOO
Organization address
address: ULICA ZAMBROWSKA 36 contact info |
PL (POZNAN) | participant | 303˙032.00 |
| 14 |
UNIVERSITEIT UTRECHT
Organization address
address: Heidelberglaan 8 contact info |
NL (UTRECHT) | participant | 284˙337.75 |
| 15 |
ETHNIKO IDRYMA EREVNON
Organization address
address: Vassileos Constantinou Avenue 48 contact info |
EL (ATHENS) | participant | 223˙194.00 |
| 16 |
SEMMELWEIS EGYETEM
Organization address
address: Ulloi ut 26 contact info |
HU (BUDAPEST) | participant | 210˙652.00 |
| 17 |
Fujikura Europe Ltd
Organization address
address: "C51 Barwell Business Park, Leatherhead Road" contact info |
UK (Chessington) | participant | 75˙060.00 |
| 18 |
"FIBERTECH CO., LTD"
Organization address
address: "KANDA-NISHIKI-CHO 3-23, CHIYODA-KU, NISHIMOTO KOSAN NISHIKICHO BLDG 10F" contact info |
JP (TOKYO CHIYODA-KU) | participant | 0.00 |
| 19 |
LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
Organization address
address: HIMES HALL 202 contact info |
US (BATON ROUGE) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'CosmoPHOS-nano is a multidisciplinary, translational and business-oriented project, aiming to accomplish the following objectives: 1) develop the CosmoPHOS system, which is a novel theranostic (diagnostic & therapeutic) nanotechnology-enabled portable combination system enabling endovascular in vivo near-infrared fluorescence molecular imaging, endovascular near-infrared targeted photodynamic therapy, real-time & follow-up therapy monitoring of atherosclerotic coronary artery disease (CAD), 2) nonclinically evaluate this system, 3) clinically validate the system after regulatory approval, & 4) reduce in the long-term CAD deaths and morbidity by up to 40%, resulting in a significant decrease of the European and global healthcare costs for CAD, increasing the income of the European healthcare industry from CAD market which is the global largest. The CosmoPHOS-nano consortium has a five year history of successful collaboration between the industrial and academic partners, and its funding would underpin a team devoted to delivering a novel powerful & affordable healthcare solution against the leading cause of death, without the need for heavy and expensive medical equipment. The CosmoPHOS system consists of two interacting components: a) targeted theranostic near-infrared photoactivatable biocompatible nanomedicines, and b) medical devices. After systemic administration, the nanomedicines targeted accumulate in coronary atherosclerotic plaques, followed by endocoronary photoactivation and detection by the medical devices, enabling molecular imaging, targeted therapy, real-time & follow-up therapy monitoring of CAD. Preliminary in vitro & in vivo successful experimental results, as well as parts of the CosmoPHOS system are already available from the prior five year collaboration. The project plan includes: A) nonclinical R&D (30 months); B) nonclinical validation & regulatory approval (18 months); C) first-in-man phase-I clinical trial in 20 CAD patients (12 months).'
Altri progetti dello stesso programma (FP7-NMP)
METALMORPHOSIS (2013)
Optimization of joining processes for new automotive metal-composite hybrid parts
Read MoreNMP-MANUFUTURE (2009)
EUROPEAN INDUSTRIAL BREAKTHROUGH LEADING TOWARDS AN INTEGRATED COMPETITIVE SUSTAINABLE INDUSTRY
Read MoreSIMBA (2009)
Scaling-up of ICP technology for continuous production of Metallic nanopowders for Battery Applications
Read More